Abubacar, Men-ima D.

HRN: 22-45-05  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/03/2023
CEFUROXIME 1.5GM (VIAL)
01/03/2023
01/10/2023
IV
1.5g
Q12
Fracture, For ORIF
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Bone & Joint    Compliance to guidelines: Non-compliant To Guidelines

Initial appropriateness: No  Wrong Dose  Wrong Dose

Final appropriateness: No  Wrong Dose  Wrong Dose

Overall appropriateness: No  Wrong Dose

Intervention



Type of Intervention done:

                    

           


Acceptance: